3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
2
Breast Neoplasms
2
Urinary Incontinence
1
Sleep Wake Disorders
1
Sleep Initiation and Maintenance Disorders
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Colonic Neoplasms
1
Interventions
Cisplatin
3
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Radiation
2
Platinum
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cyclophosphamide
2
Congresses as Topic
2
Brachytherapy
2
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
2
1,2-diaminocyclohexaneplatinum II citrate
2
rocakinogene sifuplasmid
1
durvalumab
1
alovudine
1
adavosertib
1
Vaccines, Synthetic
1
VGX-3100
1
Sonazoid
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
MEDI0457
1
Interleukin-2
1
Immunoglobulin G
1
Fondaparinux
1
Fluorodeoxyglucose F18
1
Fentanyl
1
Disulfides
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Vaginal Neoplasms
×
Behavior Therapy
×
Clear all
No trials found.